Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 917-923 , November 2007

SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia–reperfusion model

  • Wei Fang

      Affiliations

    • Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
    • W. Fang and F. Wang contributed equally to this work.
    • ,
  • Feng Wang

      Affiliations

    • Nuclear Medicine Department, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing 210006, China
    • W. Fang and F. Wang contributed equally to this work.
    • ,
  • Shundong Ji

      Affiliations

    • Jiangsu Institute of Hematology, 1st Hospital of Suzhou University, Suzhou 215006, China
    • ,
  • Xiaoguang Zhu

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, WI 53226, USA
    • ,
  • Heidi T. Meier

      Affiliations

    • Clinical Veterinarian and Radiology Research, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, WI 53295, USA
    • ,
  • Robert S. Hellman

      Affiliations

    • Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, WI 53226, USA
    • ,
  • Kevin M. Brindle

      Affiliations

    • MRC Laboratory of Molecular Biology, Cambridge CB2 2QH, UK
    • ,
  • Bazbek Davletov

      Affiliations

    • Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK
    • ,
  • Ming Zhao

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, WI 53226, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 414 456 4059; fax: +1 414 456 6512.

Received 14 December 2006 ,Revised 18 June 2007 ,Accepted 25 June 2007.

References 

  1. Jugdutt BI, Idikio HA. Apoptosis and oncosis in acute coronary syndromes: assessment and implications. Mol Cell Biochem. 2005;270:177–200
  2. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 2002;55:438–455
  3. Freude B, Masters TN, Kostin S, Robicsek F, Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol. 1998;93:85–89
  4. Maisch B. How cardiac cells die — necrosis, oncosis and apoptosis. Herz. 1999;24(3):181–188
  5. Van Cruchten S, Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol. 2002;31:214–223
  6. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207–2216
  7. Rucker-Martin C, Henaff M, Hatem SN, Delpy E, Mercadier JJ. Early redistribution of plasma membrane phosphatidylserine during apoptosis of adult rat ventricular myocytes in vitro. Basic Res Cardiol. 1999;94:171–179
  8. Bennett MR, Gibson DF, Schwart S, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res. 1995;77:1136–1142
  9. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349–6354
  10. Blankenberg FG. Recent advances in the imaging of programmed cell death. Curr Pharm Des. 2004;10:1457–1467
  11. Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C, Dierckx RA, Slegers G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging. 2004;31:887–919
  12. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. 2001;7:1241–1244
  13. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209–212
  14. Thimister PW, Hofstra L, Liem IH, et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med. 2003;44:391–396
  15. Zhao M, Zhu X, Ji S, et al. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for the non-invasive imaging of acute myocardial infarction. J Nucl Med. 2006;47:1367–1374
  16. Zhu X, Li Z, Zhao M. Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion. J Nucl Med. 2007;48:1031–1036
  17. Jung HI, Kettunen MI, Davletov B, Brindle KM. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem. 2004;15:983–987
  18. Tesic M, Sheldon KM, Ballinger JR, et al. Labeling small quantities of monoclonal antibody and their F(ab′)2 fragments with technetium-99m. Nucl Med Biol. 1995;22:451–457
  19. Kawamoto K, Herz F, Wolley RC, Hirano A, Koss LG. Flow cytometric analysis of the DNA content in cultured human brain tumor cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 1980;35:11–17
  20. Fritzberg AR, Beaumier PL. Targeted proteins for diagnostic imaging: does chemistry make a difference?. J Nucl Med. 1992;33:394–397
  21. Verbeke K, Hjelstuen O, Debrock E, Cleynhens B, De Roo M, Verbruggen A. Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agents. Nucl Med Commun. 1995;16:942–957
  22. Steffens MG, Oosterwijk E, Kranenborg MH, et al. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med. 1999;40:829–836
  23. Qu T, Wang Y, Zhu Z, Rusckowski M, Hnatowich DJ. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm. Nucl Med Commun. 2001;22:203–215
  24. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med. 2004;45:1536–1541
  25. Luckcuck T, Trotter PJ, Walker JH. Localization of annexin V in the adult and neonatal heart. Biochem Biophys Res Comm. 1997;238:622–628
  26. Pula G, Bianchi R, Ceccarelli P, Giambanco I, Donato R. Characterization of mammalian heart annexins with special reference to CaBP33 (annexin V). FEBS Lett. 1990;277:53–58
  27. Spreca A, Rambotti MG, Giambanco I, Pula G, Bianchi R, Ceccarelli P, et al. Immunocytochemical localization of annexin V (CaBP33), a Ca(2+)-dependent phospholipid- and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart. J Cell Physiol. 1992;152:587–598
  28. Doubell AF, Lazure C, Charbonneau C, Thibault G. Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart. Cardiovasc Res. 1993;27:1359–1367
  29. Sarda-Mantel L, Michel JB, Rouzet F, Martet G, Louedec L, Vanderheyden JL, et al. Eur J Nucl Med Mol Imaging. 2006;33:239–245
  30. Zhang X, Rizo J, Sudhof TC. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I. Biochemistry. 1998;37:12395–12403
  31. Sutton RB, Davletov BA, Berghuis AM, Sudhof TC, Sprang SR. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell. 1995;80:929–938

PII: S0969-8051(07)00176-X

doi: 10.1016/j.nucmedbio.2007.06.014

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 917-923 , November 2007

Article Tools

* Image Usage & Resolution